dc.contributor.author |
Gallwitz, Baptist |
|
dc.date.accessioned |
2024-11-27T13:50:32Z |
|
dc.date.available |
2024-11-27T13:50:32Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1664-2392 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/159158 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Lausanne : Frontiers Research Foundation |
de_DE |
dc.relation.uri |
https://dx.doi.org/10.3389/fendo.2021.760153 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations |
de_DE |
dc.type |
Article |
de_DE |
utue.publikation.seiten |
Article Nr. 760153 |
de_DE |
utue.personen.roh |
Meier, Jursi J. |
|
utue.personen.roh |
Gallwitz, Baptist |
|
utue.personen.roh |
Giorgino, Francesco |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Endocrinology |
de_DE |
dcterms.isPartOf.ZS-Volume |
12; |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |